In mouse colitis model, MCC950 was demonstrated to act on NLRP3 by inhibiting ASC oligomerization and caspase-1 dependent activation of IL-1β and IL-18, and reducing the levels of pro-inflammatory cytokines [51]. The gene discussed is IL1B; the disease is colitis.